| Functional pathways | pValue |
---|---|---|
1 | Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling | 1.53E-13 |
2 | Cell adhesion_ECM remodeling | 1.03E-11 |
3 | Cytoskeleton remodeling_Cytoskeleton remodeling | 7.54E-11 |
4 | Development_Regulation of epithelial-to-mesenchymal transition (EMT) | 9.43E-11 |
5 | Cell adhesion_Chemokines and adhesion | 1.75E-10 |
6 | Oxidative phosphorylation | 1.99E-10 |
7 | Development_TGF-beta-dependent induction of EMT via MAPK | 2.05E-09 |
8 | DNA damage_Brca1 as a transcription regulator | 3.36E-09 |
9 | Cytoskeleton remodeling_Reverse signaling by ephrin B | 6.64E-09 |
10 | LRRK2 in neurons in Parkinson’s disease | 2.32E-08 |
11 | Apoptosis and survival_BAD phosphorylation | 5.22E-08 |
12 | Development_TGF-beta-dependent induction of EMT via RhoA, PI3K and ILK | 5.30E-08 |
13 | Cytoskeleton remodeling_Role of PKA in cytoskeleton reorganisation | 1.30E-07 |
14 | Transcription_Androgen Receptor nuclear signaling | 2.02E-07 |
15 | Immune response_MIF-induced cell adhesion, migration and angiogenesis | 3.06E-07 |
16 | Immune response_MIF - the neuroendocrine-macrophage connector | 3.06E-07 |
17 | Development_TGF-beta-dependent induction of EMT via SMADs | 5.02E-07 |
18 | Cell adhesion_Integrin-mediated cell adhesion and migration | 6.77E-07 |
19 | Transport_Clathrin-coated vesicle cycle | 7.47E-07 |
20 | Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion | 1.27E-06 |